Market Analysis and Insights: Global CRISPR And CRISPR-Associated Genes Market
Due to the pandemic of COVID-19, the global CRISPR And CRISPR-Associated Genes Market size is estimated to be worth US$ million in 2022 and is expected to reach the size of US$ million by 2028 growing at a CAGR of % during the forecast period. Fully considering the economic change by this health crisis, Genome Editing accounted for % of the global CRISPR And CRISPR-Associated Genes Market in 2021 and is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Biotechnology Companies segment is altered to a % CAGR throughout this forecast period.
North America held a significant share of the global CRISPR And CRISPR-Associated Genes Market market in 2021 and was valued at US$ million in 2021. It is estimated to grow with a CAGR of % during the forecast period of 2022-2028 and is estimated to reach US$ million by 2028.
China CRISPR And CRISPR-Associated Genes Market size is valued at US$ million in 2021, while the US and Europe CRISPR And CRISPR-Associated Genes Market are US$ million and US$ million, respectively. The share of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China’s share will reach % in 2028, trailing a CAGR of % through the forecast period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe CRISPR And CRISPR-Associated Genes Market landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of CRISPR And CRISPR-Associated Genes Market include Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, Sangamo Biosciences Inc., Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, Origene Technologies, , etc. In 2021, the global top five players have a share of approximately % in terms of revenue.
In terms of the production, this report researches the CRISPR And CRISPR-Associated Genes Market capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of the sales, this report focuses on the sales of CRISPR And CRISPR-Associated Genes Market by region (region level and country level), by company, by Type and by Application from 2017 to 2022 and forecast to 2028.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
COVID-19 Impact Analysis on CRISPR And CRISPR-Associated Genes Market Market
The report highlights the effects of the outbreak of COVID-19 on the development of the CRISPR And CRISPR-Associated Genes Market market across the globe. The authors studied the changes which affected the production/manufacturing, supply chain, consumption, and the demand/supply side. With the help of this report, the reader will get acquainted with the measures which helped the key industry players to get the CRISPR And CRISPR-Associated Genes Market market back to the pre-covid levels.
Global CRISPR And CRISPR-Associated Genes Market Market: Drivers and Restrains
The research report examines market trends, segments, applications, restraints and drivers which affect the global CRISPR And CRISPR-Associated Genes Market market. This report covers the global market for production volume, production by region, and pricing analysis for each type from 2018 to 2028. Factors influencing market development are important because they may be used to design diverse strategies for capturing the lucrative opportunities that exist in the continuously growing industry. In addition, market expert opinions have been incorporated for a better knowledge of the market.
CRISPR And CRISPR-Associated Genes market is segmented by
players, region (country), by Type and by Application. Players,
stakeholders, and other participants in the global CRISPR And
CRISPR-Associated Genes market will be able to gain the upper hand
as they use the report as a powerful resource. The segmental
analysis focuses on revenue and forecast by Type and by Application
for the period 2017-2028.
Segment by Type
Genome Editing
Genetic Engineering
GRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Company
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA